Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates
The in vitro activities of tigecycline against 1,924 clinical isolates were examined. The new glycylcycline exhibited excellent activity against all gram-positive cocci (MICs at which 90% of the isolates tested were inhibited [MIC(90)s], ≤1 μg/ml). In addition, it was also very potent against most m...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphov: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
2003
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149011/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499224/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.400-404.2003 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|